XOMA Corporation (XOMA) Announces Clinical Study Investigating Gevokizumab in Patients With Non-Infectious Anterior Scleritis Has Opened for Enrollment at the National Eye Institute
4/10/2013 11:20:58 AM
More...
|
XOMA Corporation (XOMA) Announces Servier Has Initiated a Proof-of-Concept Gevokizumab Study in Patients With a History of Acute Coronary Syndrome
11/29/2012 10:34:42 AM
More...
|
XOMA Corporation (XOMA)'s Nails Hypertension Trial, Seeks to Sublicense Drug
11/21/2012 8:00:05 AM
More...
|
XOMA Corporation (XOMA) Lands Orphan Drug Status for Eye Disease Treatment
8/22/2012 2:55:05 PM
More...
|
CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility
7/31/2012 9:57:56 AM
More...
|
Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform
7/31/2012 9:50:16 AM
More...
|
XOMA (US) LLC (XOMA) Will Move Its Corporate Domicile to Delaware
1/3/2012 9:48:56 AM
More...
|
XOMA (US) LLC (XOMA) Secures $10 Million Term Loan
1/3/2012 6:46:50 AM
More...
|
XOMA Ltd. (XOMA) CEO Quits After Four-Year Push to Go Commercial
9/1/2011 7:47:18 AM
More...
|
XOMA Ltd. (XOMA) Release: Interim Three Month Data From Ongoing Six Month XOMA 052 Phase 2a Trial Support Safety and Biological Activity
1/7/2011 9:51:51 AM
More...
|